Key Considerations for Reshoring U.S. Drug Manufacturing
Nota Bene Episode 100: The New World Trade Order with Scott Maberry
Personal Jurisdiction: Not what you learned in law school [More with McGlinchey Ep. 4]
Foreign device manufacturers should anticipate greater chance of FDA inspection under new FDA leadership
For years, the U.S. International Trade Commission maintained that the potent remedies available under Section 337 were unavailable to intellectual property owners considered to be nothing more than “mere importers.” That...more
Halo Elecs., Inc. v. Pulse Elecs., Inc. and Pulse Elecs. Corp. - In a case exploring the limits of what constitutes a sale or offer for sale “within the United States” under 35 U.S.C. § 271(a), the U.S. Court of...more
In This Issue: • Licensing to Foreign Manufacturers Satisfies Domestic Industry • Appeal Found to Be Moot in Light of “Side Bet” • Mere Design Choice Leads to Obviousness Finding • Design Patent Infringement...more